Journey Medical (DERM) - 2025 Q4 - Annual Results

Exhibit 99.1 Journey Medical Corporation Reports Full-Year 2025 Financial Results and Recent Corporate Highlights Total revenues were $61.9 million in FY2025 compared to $56.1 million in FY2024 Emrosi generated net revenues of $14.7 million during the full-year period after its launch in early April 2025 Approximately 53,000 total prescriptions were filled for Emrosi during FY2025 Payer access for Emrosi available to over 100 million U.S. commercial lives · Revenues totaled $61.9 million for the year ended ...